Recombinant IGFBP7 anticorps (PE)
Aperçu rapide pour Recombinant IGFBP7 anticorps (PE) (ABIN7867328)
Antigène
Voir toutes IGFBP7 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- PE-conjugated Anti-IGFBP7 antibody(DMC422), IgG1 Chimeric mAb
-
Purification
- Purified from cell culture supernatant by affinity chromatography
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Flow Cyt 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid PBS with 0.05 % Proclin300, 1 % BSA
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2°C-8°C for 6 months
-
Date de péremption
- 6 months
-
-
- IGFBP7 (Insulin-Like Growth Factor Binding Protein 7 (IGFBP7))
-
Autre désignation
- IGFBP7
-
Sujet
-
Synonyms: IBP-7, TAF, IGFBP-rP1, MAC25 protein
Target Background: This gene encodes a member of the insulin-like growth factor (IGF)-binding protein (IGFBP) family. IGFBPs bind IGFs with high affinity, and regulate IGF availability in body fluids and tissues and modulate IGF binding to its receptors. This protein binds IGF-I and IGF-II with relatively low affinity, and belongs to a subfamily of low-affinity IGFBPs. It also stimulates prostacyclin production and cell adhesion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene, and one variant has been associated with retinal arterial macroaneurysm (PMID:21835307).
-
UniProt
- Q16270
-
Pathways
- Growth Factor Binding
Antigène
-